Drawing for SINUS-12

USPTO serial 78159315

SINUS-12

Reviewed by CopyMark Law Group

Status 607
Filing date
Status date
Registration date
—
Examiner
DUBOIS, SUSAN L
Law office
TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SINUS-12?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB666 3RD AVE 10TH FLNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, namely expectorant and decongestantACTIVESep 30, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 13, 2006MAB7ABANDONMENT NOTICE MAILED - DEFECTIVE USE STATEMENT—
Feb 13, 2006ABN7ABANDONMENT - DEFECTIVE USE STATEMENT—
Feb 8, 2005EX3GSOU EXTENSION 3 GRANTED—
Jan 10, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 8, 2005EXT3SOU EXTENSION 3 FILED—
Aug 8, 2004EX2GSOU EXTENSION 2 GRANTED—
Aug 4, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2004UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Jul 8, 2004EXT2SOU EXTENSION 2 FILED—
Jul 8, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 2, 2004DOCKASSIGNED TO EXAMINER—
May 31, 2004SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 24, 2004CFITCASE FILE IN TICRS—
May 18, 2004IUAFUSE AMENDMENT FILED—
May 18, 2004EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 23, 2003EX1GSOU EXTENSION 1 GRANTED—
Oct 14, 2003EXT1SOU EXTENSION 1 FILED—
Oct 14, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 15, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 26, 2003NPUBNOTICE OF PUBLICATION—
Feb 10, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 27, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance